NCT04049552View on ClinicalTrials.gov

RAPA-Keloid Study of Keloid Regression

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

January 24, 2020

Primary Completion Date

August 24, 2020

Study Completion Date

May 2, 2021

Conditions
Keloid
Interventions
DRUG

Rapamycin 8% Ointment

A compounded ointment containing 8% rapamycin

DRUG

Placebo

Petrolatum ointment placebo

Trial Locations (1)

78229

Audie L Murphy Memorial Veterans Hospital, San Antonio

All Listed Sponsors
lead

The University of Texas Health Science Center at San Antonio

OTHER

NCT04049552 - RAPA-Keloid Study of Keloid Regression | Biotech Hunter | Biotech Hunter